Furthermore, our data suggest that the PI3K-Akt signaling pathway might play an important role in OC patients with a high expression of CTCFL. Finally, FN1 appears to be one of the main effectors of CTCFL-driven downstream changes in OC tumor cells. Here, CTCFL is linked to neoplasm.